PATENT CLAIM ANALYSIS

Application Number: 16070279
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["546", "293000"]

Abstract:
The present invention relates to a pharmaceutical composition for preventing or treating inflammatory bowel disease, containing, as an active ingredient, a pyridinol derivative or a pharmaceutically acceptable salt thereof. A pyridinol derivative represented by chemical formula 1 or a pharmaceutically acceptable salt thereof has an excellent colitis inhibitory effect in an inflammatory bowel disease model, and thus can be useful as a medicine for preventing or treating inflammatory bowel disease.

Claim (Index 2):
The compound according to  claim 1 , wherein R 2 , R 3  and R 4  are each independently alkyl having 1 to 4 carbon atoms,\n R 5  is any one selected from the group consisting of hydrogen; alkyl having 1 to 4 carbon atoms, which is substituted or not substituted with aryl having 6 to 12 carbon atoms; and \u2014Si(R 6 ) 3 , R 6  is alkyl having 1 to 6 carbon atoms or aryl having 6 to 12 carbon atoms, and L is \u2014O\u2014, \u2014NH\u2014C(O)\u2014NH\u2014, \u2014NH\u2014C(S)\u2014NH\u2014, \u2014NH\u2014C(O)\u2014O\u2014, \u2014NH\u2014S(O) 2 \u2014NH\u2014 or \u2014NH\u2014S(O) 2 \u2014.

Metadata:
- Claim Count in Document: 12.0
- Percentile: 95.0
- Lexical Diversity: 1.61702
- Patent Class: 546.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12096432', '14784957', '10932463', '12021638', '15382872']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8310961948844396
- 35 USC 102 Novelty (BERT): 0.4968792830871435
- Combined Prediction Score: 0.79767450370471
- Mean Citation Score: 284.06497
- Max Citation Score: 291.67694
- Similarity Product: 255.9449494775521

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test